Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD).
Diana BuzovaAndrea MaugeriAntonio LiguoriCecilia NapodanoOriana Lo ReJude ObenAnna AlisiAntonio GasbarriniAntonio GriecoJan CervenyLuca MieleManlio VinciguerraPublished in: Clinical epigenetics (2020)
In summary, we identified a new circulating histone signature able to discriminate the severity of steatosis in individuals with lean MAFLD, using a rapid and non-invasive ImageStream(X)-based imaging technology.